See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2019_AILERON_THERAPEUTICS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001420565')"} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 21,775,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,290,000 |
| 3 | remainder_Assets | 1,247,000 |
| 4 | LiabilitiesCurrent | 5,370,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,342,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,454,000 |
| 9 | ResearchAndDevelopmentExpense | 18,448,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 355,000 |
| 13 | remainder_ComprehensiveNetIncome | 28,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,312,000 |
| 1 | Liabilities | 10,712,000 |
| 2 | Expenses | 31,902,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 19,600,000 |
| 5 | NetIncome | -31,547,000 |
| 6 | ComprehensiveNetIncome | -31,533,000 |
| 7 | BaseVar | 36,654,500 |
| 8 | EconomicCapitalRatio | 0.106 |
Edgar->Model Mapping
Feature Distribution
Change over Time
